{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:55:35Z","timestamp":1776988535067,"version":"3.51.4"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Solid lipid nanoparticles (SLN) based on Dynasan 114 (D114) were tested using RAW 264.7 cells. The influence of different surfactants on the cytotoxicity of this type of SLN was examined, expressed as 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) viability and the production of cytokines such as interleukin 6 (IL-6), IL-12 and tumour necrosis factor-\u03b1 (TNF-\u03b1). Results were compared with previously obtained data when peritoneal mouse macrophages were used. SLN produced with stabilizers\/surfactants such as poloxamer 188, sodium cholate, Lipoid S75, Tween 80, Poloxamine 908 and sodium dodecylsulfate were shown to be nontoxic towards RAW 264.7 cells. Cytokine production was reduced and stimulation, expressed in elevated cytokine levels, could not be found. Using cetylpyridinium chloride (CPC) as stabilizing surfactant, SLN became cytotoxic in a concentration-dependent manner. Not only were the viabilities reduced but also cytokine production. Cytotoxic effects of CPC stabilized SLN could be antagonized using cytochalasin B to block phagocytosis. D114-SLN produced with pharmaceutically accepted surfactants for intravenous injection (poloxamer 188, Lipoid S75, sodium cholate, Tween 80) were very well tolerated by the cells. Even sodium dodecylsulfate-stabilized D114-SLN did not exert toxic effects. Comparison of the RAW 264.7 data with previously obtained data from toxicity studies of D114-SLN towards peritoneal mouse macrophages showed similar results. This offers the possibility of using the RAW 264.7 cell line for cytotoxicity studies of colloidal drug carrier systems, rather than using laboratory animals as source of macrophages for these kinds of studies.<\/jats:p>","DOI":"10.1211\/0022357023754","type":"journal-article","created":{"date-parts":[[2004,7,3]],"date-time":"2004-07-03T00:22:44Z","timestamp":1088814164000},"page":"883-891","source":"Crossref","is-referenced-by-count":39,"title":["Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages\u2014impact of phagocytosis on viability and cytokine production"],"prefix":"10.1093","volume":"56","author":[{"given":"Carsten","family":"Olbrich","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, Biopharmaceutics and Biotechnology, The Free University of Berlin , Kelchstr. 31, D-12169 Berlin,","place":["Germany"]},{"name":"Schering AG, Research Laboratories , D 13342 Berlin,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadja","family":"Sch\u00f6ler","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Biopharmaceutics and Biotechnology, The Free University of Berlin , Kelchstr. 31, D-12169 Berlin,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Tabatt","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Biopharmaceutics and Biotechnology, The Free University of Berlin , Kelchstr. 31, D-12169 Berlin,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Kayser","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Biopharmaceutics and Biotechnology, The Free University of Berlin , Kelchstr. 31, D-12169 Berlin,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer Helmut","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Biopharmaceutics and Biotechnology, The Free University of Berlin , Kelchstr. 31, D-12169 Berlin,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,7,1]]},"reference":[{"key":"2024103109402505700_cit1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0167-5699(94)90137-6","article-title":"The acute phase response","volume":"15","author":"Baumann","year":"1994","journal-title":"Immunol. Today"},{"key":"2024103109402505700_cit2","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/(SICI)1097-4636(19980915)41:4<600::AID-JBM12>3.0.CO;2-I","article-title":"Flow cytometric analysis of macrophage response to ceramic and polyethylene particles: effect of size, concentration and composition","volume":"41","author":"Catelas","year":"1998","journal-title":"J. Biomed. Mater. Res."},{"key":"2024103109402505700_cit3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1165\/ajrcmb.13.5.7576690","article-title":"Activation of murine macrophages by silica particles in vitro is a process independent of silica-induced cell death","volume":"13","author":"Claudio","year":"1995","journal-title":"Am. J. Resp. Cell. Mol. Biol."},{"key":"2024103109402505700_cit4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1012059501947","article-title":"Interaction between polycyanoacrylate nanoparticles and peritoneal macrophages: MTT metabolism. NBT reduction and NO production","volume":"14","author":"Cruz","year":"1997","journal-title":"Pharm. Res."},{"key":"2024103109402505700_cit5","doi-asserted-by":"crossref","first-page":"6978","DOI":"10.1021\/bi00527a031","article-title":"Liposome-mediated delivery of deoxyribonucleic acid to cells: enhanced efficiency of delivery related to lipid composition and incubation conditions","volume":"20","author":"Fraley","year":"1981","journal-title":"Biochemistry"},{"key":"2024103109402505700_cit6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-5173(00)00639-6","article-title":"Serum protein adsorption on lipid drug conjugate nanoparticles: a comparison of species dependant adsorption patterns","volume":"214","author":"Gessner","year":"2001","journal-title":"Int. J. Pharm."},{"key":"2024103109402505700_cit7","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/S0142-9612(98)00140-9","article-title":"Polyethylene particles of a \u2018critical size\u2019 are necessary for the induction of cytokines by macrophages in vitro","volume":"19","author":"Green","year":"1998","journal-title":"Biomaterials"},{"key":"2024103109402505700_cit8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-065X.1988.tb00774.x","article-title":"Mechanism of antigen processing","volume":"106","author":"Harding","year":"1988","journal-title":"Immunol. Rev."},{"key":"2024103109402505700_cit9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0378-5173(86)90199-7","article-title":"The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages","volume":"29","author":"Illum","year":"1986","journal-title":"Int. J. Pharm."},{"key":"2024103109402505700_cit10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0024-3205(87)90138-X","article-title":"The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer \u2014 poloxamine 908","volume":"40","author":"Illum","year":"1987","journal-title":"Life Sci."},{"key":"2024103109402505700_cit11","first-page":"197","article-title":"Ornithine-containing lipids stimulate CD 14-dependent TNF-\u03b1 production from murine macrophage-like J774.1 and RAW 264.7 cells","volume":"28","author":"Kawai","year":"2000","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"2024103109402505700_cit12","doi-asserted-by":"crossref","first-page":"16 730","DOI":"10.1074\/jbc.273.27.16730","article-title":"Production of adrenomedullin in macrophage cell line and peritoneal macrophage","volume":"273","author":"Kubo","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2024103109402505700_cit13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0378-5173(92)90210-S","article-title":"Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain lengths","volume":"84","author":"Lherm","year":"1991","journal-title":"Int. J. Pharm."},{"key":"2024103109402505700_cit14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0923-2494(92)80078-Y","article-title":"Monoclonal antibody AMH152 reacts with human monocytes in culture and with inflammatory macrophages","volume":"143","author":"Martin","year":"1992","journal-title":"Res. Immunol."},{"key":"2024103109402505700_cit15","first-page":"511","article-title":"Solid lipid nanoparticles \u2014 ein neuartiger Wirkstoff-Carrier f\u00fcr Kosmetika und Pharmazeutika. 2. Mitteilung: Wirkstoff-Inkorporation. Freisetzung und Sterilisierbarkeit","volume":"59","author":"Mehnert","year":"1997","journal-title":"Pharm. Ind."},{"key":"2024103109402505700_cit16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"2024103109402505700_cit17","first-page":"379","article-title":"Colloidal carriers for controlled drug delivery and targeting \u2014 modification","volume-title":"Characterization and in vivo distribution","author":"M\u00fcller","year":"1991"},{"key":"2024103109402505700_cit18","volume-title":"Arzneistofftr\u00e4ger aus festen Lipidteilchen","author":"M\u00fcller","year":"1996"},{"key":"2024103109402505700_cit19","first-page":"462","article-title":"Solid Lipid Nanoparticles (SLN): phagocytic uptake, in vitro cytotoxity and in vivo biodegradation. 1st Communication","volume":"61","author":"M\u00fcller","year":"1999","journal-title":"Pharm. Ind."},{"key":"2024103109402505700_cit20","first-page":"564","article-title":"Solid Lipid Nanoparticles (SLN): Phagocytic uptake. in vitro cytotoxity and in vivo biodegradation. 2nd Communication","volume":"61","author":"M\u00fcller","year":"1999","journal-title":"Pharm. Ind."},{"key":"2024103109402505700_cit21","first-page":"62","article-title":"Solid lipid nanoparticles (SLN) \u2014 an alternative colloidal carrier system for controlled drug delivery","volume":"41","author":"M\u00fcller","year":"1995","journal-title":"Eur. J. Pharm."},{"key":"2024103109402505700_cit22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/10611869609015973","article-title":"Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407","volume":"4","author":"M\u00fcller","year":"1996","journal-title":"J. Drug Target."},{"key":"2024103109402505700_cit23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0168-3659(97)01653-2","article-title":"Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes","volume":"47","author":"M\u00fcller","year":"1997","journal-title":"J. Control. Release"},{"key":"2024103109402505700_cit24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1023\/A:1012043315093","article-title":"Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant","volume":"14","author":"M\u00fcller","year":"1997","journal-title":"Pharm. Res."},{"key":"2024103109402505700_cit25","volume-title":"Stabilitats-, Biokompatibilit\u00e4ts-optimiertes Adjuvans (SBA) zur Erh\u00f6hung der humoralen und zellul\u00e4ren Immunantwort","author":"M\u00fcller","year":"1999"},{"key":"2024103109402505700_cit26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery \u2014 a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"2024103109402505700_cit27","first-page":"359","article-title":"Large scale production of solid lipid nanoparticles (SLN) and nanosuspensions (DissoCubesTM)","volume-title":"Handbook of pharmaceutical controlled release technology","author":"M\u00fcller","year":"2000"},{"key":"2024103109402505700_cit28","first-page":"568","article-title":"Solid lipid nanoparticles (SLN) as vaccine adjuvant \u2014 study in sheep with a mycoplasma bovis antigen and stability testing","volume":"27","author":"Olbrich","year":"2000","journal-title":"Intern. Symp. Control. Rel. Bioact. Mater."},{"key":"2024103109402505700_cit29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jconrel.2004.02.024","article-title":"Lipid-drug conjugate (LDC) nanoparticles of the hydrophilic drug diminazene \u2014 cytotoxicity testing and mouse serum adsorption","volume":"96","author":"Olbrich","year":"2004","journal-title":"J. Control. Release"},{"key":"2024103109402505700_cit30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-4615-1823-5_10","article-title":"MF59, Design and evaluation of a safe and potent adjuvant for human vaccines","volume":"6","author":"Ott","year":"1995","journal-title":"Pharm. Biotechnol."},{"key":"2024103109402505700_cit31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0168-1605(98)00197-4","article-title":"Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium","volume":"46","author":"Park","year":"1999","journal-title":"Int. J. Food Microbiol."},{"key":"2024103109402505700_cit32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1023\/A:1011973625803","article-title":"Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecylcyanoacrylate amphiphilic copolymer","volume":"15","author":"Peracchia","year":"1998","journal-title":"Pharm Res."},{"key":"2024103109402505700_cit33","first-page":"950","article-title":"Antibody-dependant killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPSJ","volume":"119","author":"Ralph","year":"1977","journal-title":"Immunology"},{"key":"2024103109402505700_cit34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0092-8674(78)90101-0","article-title":"Functional macrophage cell lines transformed by Abelson leukemia virus","volume":"15","author":"Raschke","year":"1978","journal-title":"Cell"},{"key":"2024103109402505700_cit35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0168-3659(92)90101-V","article-title":"In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. I. Effect of analytical parameters. particle size and particle concentration","volume":"22","author":"Rudt","year":"1992","journal-title":"J. Control. Release"},{"key":"2024103109402505700_cit36","volume-title":"Interaktion von Solid Lipid Nanoparticles (SLN), neuartigen Wirkstoff-Carriern, mit mononukle\u00e4ren Zellen. 51","author":"Sch\u00f6ler","year":"1999"},{"key":"2024103109402505700_cit37","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/026520400417685","article-title":"Effect of solid lipid nano-particles (SLN) on cytokine production and the viability of murine peritoneal macrophages","volume":"17","author":"Sch\u00f6ler","year":"2000","journal-title":"J. Microencapsulation"},{"key":"2024103109402505700_cit38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0378-5173(99)00430-5","article-title":"Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages","volume":"23","author":"Sch\u00f6ler","year":"2000","journal-title":"Int. J. Pharm."},{"key":"2024103109402505700_cit39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0378-5173(01)00660-3","article-title":"Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages","volume":"221","author":"Sch\u00f6ler","year":"2000","journal-title":"Int. J. Pharm."},{"key":"2024103109402505700_cit40","first-page":"110","article-title":"A review of block polymer surfactants","volume":"54","author":"Schmolka","year":"1977","journal-title":"J. Am. Chem. Soc."},{"key":"2024103109402505700_cit41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0168-3659(94)90047-7","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production. characterisation and sterilisation","volume":"30","author":"Schwarz","year":"1993","journal-title":"J. Control. Release"},{"key":"2024103109402505700_cit42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0168-3659(00)00269-8","article-title":"Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nano-particles on M5076 cells in vitro","volume":"68","author":"Soma","year":"2000","journal-title":"J. Control. Release"},{"key":"2024103109402505700_cit43","first-page":"845","article-title":"The mononuclear phagocyte system. A new classification of macrophages and their precursor cells","volume":"46","author":"Van Furth","year":"1972","journal-title":"Bull. WHO."},{"key":"2024103109402505700_cit44","volume-title":"Phagocytic engulfment and cell adhesivness as cellular surface phenomena","author":"Van Oss","year":"1975"},{"key":"2024103109402505700_cit45","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1749-6632.1983.tb35197.x","article-title":"Interaction of phagocytes with other blood cells and with pathogenic and nonpathogenic microbes","volume":"416","author":"Van Oss","year":"1983","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2024103109402505700_cit46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-5793(97)01283-0","article-title":"Cationic lipids destabilize lysosomal membrane in vitro","volume":"417","author":"Wattiaux","year":"1997","journal-title":"FEBS Lett."},{"key":"2024103109402505700_cit47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-3659(99)00007-3","article-title":"Body distribution in mice of intravenously injected campothecin solid lipid nanoparticles and drug targeting effect on brain","volume":"59","author":"Yang","year":"1999","journal-title":"J. Control. Release"},{"key":"2024103109402505700_cit48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0939-6411(97)00150-1","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery. drug release and release mechanism","volume":"45","author":"zur M\u00fchlen","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"2024103109402505700_cit49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0005-2736(94)90066-3","article-title":"DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action","volume":"1189","author":"Zhou","year":"1994","journal-title":"Biochim. Biophys. Acta."}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1211%2F0022357023754","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/56\/7\/883\/60260427\/0022357023754.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/56\/7\/883\/60260427\/0022357023754.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T10:16:20Z","timestamp":1730369780000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/56\/7\/883\/6147326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,1]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2004,7,1]]},"published-print":{"date-parts":[[2004,7,1]]}},"URL":"https:\/\/doi.org\/10.1211\/0022357023754","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2004,7]]},"published":{"date-parts":[[2004,7,1]]}}}